Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genetics of glaucoma]

X D Martin1

  • 1Clinique ophtalmologique universitaire, Zurich.

Revue Medicale De La Suisse Romande
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Glaucoma genetics research is advancing, identifying specific genes for juvenile glaucoma and understanding multifactorial inheritance for open-angle glaucoma. This genetic insight promises revolutionary, etiological treatments for glaucoma within three decades.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dorzolamide-induced immune thrombocytopenia: a case report and literature review.

Journal of glaucoma·2001
Same author

Type a syndrome of insulin resistance: anterior chamber anomalies of the eye and effects of insulin-like growth factor-I on the retina.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2001
Same author

Xanthurenic acid derivative formation in the lens is responsible for senile cataract in humans.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·1996
Same author

Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·1996
Same author

3-hydroxykynurenine transamination leads to the formation of the fluorescent substances in human lenses.

European journal of ophthalmology·1996
Same author

Deamination of 3-hydroxykynurenine in bovine lenses: a possible mechanism of cataract formation in general.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·1995
Same journal

Accelerated sedimentation and hyperproteinemia.

Revue medicale de la Suisse romande·2010
Same journal

Treatment of a hydrothorax.

Revue medicale de la Suisse romande·2010
Same journal

Edema on pilgrim.

Revue medicale de la Suisse romande·2010
Same journal

Lymphosarcoma of the pancreatic compartment.

Revue medicale de la Suisse romande·2010
Same journal

Relief photography.

Revue medicale de la Suisse romande·2010
Same journal

Suture and nerve graft.

Revue medicale de la Suisse romande·2010
See all related articles

Area of Science:

  • Ophthalmology and Genetics
  • Molecular Biology and Disease Gene Discovery

Context:

  • Glaucoma is a leading cause of blindness, necessitating advanced research into its underlying mechanisms.
  • Recent molecular biology advancements are crucial for identifying glaucoma-associated genetic factors.

Purpose:

  • To review the genetic basis of various glaucoma types, including juvenile and primary open-angle glaucoma.
  • To explore the implications of genetic discoveries for future glaucoma diagnosis and treatment strategies.

Summary:

  • The first glaucoma-related gene was localized to chromosome 1q21-q31 in 1993, with ongoing sequencing efforts.
  • Juvenile glaucomas exhibit autosomal dominant inheritance, while primary open-angle glaucomas follow a multifactorial model.
  • Potential links between glaucoma, diabetes mellitus, and chromosomal anomalies are being investigated.

Related Experiment Videos

Impact:

  • Understanding glaucoma genetics will fundamentally transform treatment from symptomatic to etiological approaches.
  • Future treatments may involve gene correction or modulation, offering radical improvements in glaucoma management.
  • Genetic discoveries are expected to revolutionize glaucoma care within the next thirty years.